Parliamentary panel flags under-utilisation of funds given in pandemic

[ad_1]

Read More/Less


The Parliamentary Standing Committee on Labour has raised concerns over the Labour and Employment Ministry missing physical targets for schemes and asked the Ministry to look into why it was unable to use funds allocated to it, particularly during the pandemic, in an optimal way.

In its report on the demand for grants for 2021-2022 that was presented in Parliament on Tuesday, the panel said: “The Committee also desires that the Ministry seriously look into the infrastructural or procedural constraints impeding optimal utilisation of funds especially made available during the pandemic (sic).”

The report said there had been an increase in the allocation for the Ministry from ₹12,065.49 crore in the Budget Estimate (BE) to ₹13,719.56 crore in the Revised Estimate (RE) in 2020-2021 due to the launch of the Pradhan Mantri Gareeb Kalyan Yojana (PMGKY) during the pandemic to boost the economy.

“The Committee notes that though an allocation of ₹4,860 crore has been made for the PMGKY in the First Supplementary Demand for Grants, only ₹2,566 crore could be spent as on 15.02.2021, which amounts to utilisation of only 52.8% of the funds. Further, there has been a downward revision of the allocation for the scheme to ₹2,600 crore at the RE Stage. This apart, ₹1,000 crore has been allocated for Atmanirbhar Bharat Rojgar Yojana (ABRY) at RE stage,” the report said.

While ₹1,000 crore was allocated for the ABRY scheme in 2020-2021 at the time of the second supplementary demand for grants, the utilisation of funds stood at “nil due to non-dispersal of funds”.

The report said the Ministry had not utilised funds in an even manner over the four quarters of the current financial year.

“The Committee also observes that gross underutilisation of funds has impacted the performance of certain schemes thereby defeating the laudable intent of these schemes in benefiting the targeted group. The Committee, therefore, exhorts upon the Ministry to act on improving the implementation machinery and work towards bringing about more efficiency, especially during these critical times. (sic).”

The panel said it was ‘concerned’ that the Ministry had not been able to meet physical targets in many major schemes. The main cause of this was the pandemic, it said. While some schemes, like the coaching-cum-guidance centres for the SCs/STs, had achieved the targets, others, like the training centres for working children and the Pradhan Mantri Shram Yogi Maan-Dhan Yojana, which achieved 1.18 lakh enrolments out of the target of 2 crore new enrolments, had not.

“The Committee, while acknowledging the fact that the pandemic may have had a deleterious effect on the implementing agencies, nevertheless, cannot help noting that the targeted beneficiaries of these schemes were also the ones who were severely hit by the pandemic (sic),” it said.

With regard to the Employees Provident Fund Organisation, the report said it was concerned about the increase in pending grievances. It said the Ministry must take steps to reduce the pending grievances from 30,411 as of the end of 2020.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Mark Zuckerberg announces new Facebook tools to help people get vaccinated

[ad_1]

Read More/Less


Facebook CEO Mark Zuckerberg has announced that the company will be launching a global campaign to help people get vaccinated amidst the ongoing COVID-19 pandemic. “We’ve already connected over 2 billion people to authoritative Covid-19 information. Now that many countries are moving towards vaccinations for all adults, we’re working on tools to make it easier for everyone to get vaccinated as well,” Zuckerberg said in a Facebook post.

Facebook will be using all three major platforms – Facebook, Instagram and WhatsApp to take the initiative further. Here’s what the company plans on doing.

Facebook vaccination tool

Facebook will be launching a new tool on the platform that will show users where and when they can go to get vaccinated. The tool will also provide users with a link to make an appointment. The tool will be visible in the COVID Information Center which will be visible in the Facebook News Feed. While the tool is limited to the US for now, Facebook says it will be supported in 71 different languages. It plans to expand to other countries as vaccines are available more widely. In India, vaccination is available for all citizens above 60 and those who are above 45 but suffering from comorbidity.

COVID News Center on Instagram

Facebook will also be bringing its COVID News Center to Instagram, allowing more people access to the COVID-related news update centre which will now also show vaccination-related information.

WhatsApp chatbots to help register for vaccines

Zuckerberg also mentioned in his post that the company will be working with health authorities and governments to expand their WhatsApp chatbots to help people register for vaccines. “More than 3 billion messages related to Covid have already been sent by governments, nonprofits and international organisations to citizens through official WhatsApp chatbots, so this update will help with the vaccination effort as well,” the post said.

[ad_2]

READ FULL ARTICLE HERE

Non-invasive skin swab tests can quickly detect COVID-19: study

[ad_1]

Read More/Less


The samples were collected by gently swabbing a skin area rich in sebum such as the face, neck or back

Non-invasive skin swab samples may be enough to detect the novel coronavirus quickly, according to a study published in the E Clinical Medicine journal.

Researchers at the University of Surrey in the U.K. noted that COVID-19 pandemic has led to an unprecedented demand for testing — for diagnosis and prognosis — as well as for investigation into the impact of the disease on the host metabolism.

Sampling sebum — an oily, waxy substance produced by the body’s sebaceous glands — has the potential to support both needs by looking at what the virus does to us, rather than looking for the virus itself, they said.

The most widely used approach to testing for COVID-19 requires a polymerase chain reaction (PCR) test, which involves taking a swab of the back of the throat and far inside the nose.

The researchers collected sebum samples from 67 hospitalised patients — 30 who had tested positive for COVID-19 and 37 who had tested negative. The samples were collected by gently swabbing a skin area rich in sebum such as the face, neck or back.

The team analysed the samples by using liquid chromatography mass spectrometry and a statistical modelling technique to differentiate between the COVID-19 positive and negative samples.

The researchers, including those from the Universities of Manchester and Leicester, found that patients with a positive COVID-19 test had lower lipid levels — or dyslipidemia — than their counterparts with a negative test.

They noted that the accuracy of the findings increased further when medication and additional health conditions were controlled.

“Our study suggests that we may be able to use non-invasive means to test for diseases such as COVID-19 in the future — a development which I am sure will be welcomed by all,” said Melanie Bailey, co-author of the study from the University of Surrey.

Matt Spick, co-author of the study from the University of Surrey noted that COVID-19 damages many areas of metabolism.

“In this work, we show that the skin lipidome can be added to the list, which could have implications for the skin’s barrier function, as well as being a detectable symptom of the disease itself,” Spick said.

Investigating new methods of diagnosis and surveillance in a new disease such as COVID-19 that has had such a devastating effect on the world is vital, according to George Evetts, Consultant in Anaesthesia & Intensive Care Medicine at Frimley Park Hospital. “Sebum sampling is a simple, non-invasive method that shows promise for both diagnostics and monitoring of the disease in both a healthcare and a non-healthcare setting,” Evetts added.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Tamil Nadu Agriculture University’s renovated botanical garden opens with new attractions

[ad_1]

Read More/Less


Tamil Nadu’s second largest garden has been renovated, at the age of 113. Now, a walk through the refreshed botanical garden of Tamil Nadu Agriculture University is a riot of colours, scents and lessons in flora

A canopy of towering gulmohar trees streak the air with yellow as I begin my walk at the Tamil Nadu Agriculture University’s (TNAU) renovated botanical garden in Coimbatore. Adding pleasure to the view is a cool breeze. A few steps away from the profuse yellow, a riot of orange blooms dot the ground. Next to this bay of flowering shrubs of rose, yellow, and orange tecoma flowers are vast stretches of green lawns.

Symmetrical garden with flowering shrubs

The renovated front of the 113-year-old garden, second largest in the State after the Government Botanical Garden in Udhagamandalam (Ooty), has re-laid lawn grass on both sides, central fountains, and gazebos. A pond will be added with water lillies and lotuses.

All plants and trees have been labelled using QR coding system

All plants and trees have been labelled using QR coding system  
| Photo Credit:
Siva Saravanan S

The pavement on the main drive is flanked by rows of false Ashoka trees, foliage trees that branch out in tiers, and cordia trees that bear saffron-coloured flowers all through the year. Flowering climbers and clerodendrom shrubs with white and red blossoms form the hedges around arches at the lawns. A QR code displayed next to the trees and plants displays both scientific and common names.

Maze garden

Spread across 47 acres, the garden has over 800 species of flora, both exotic and native, and serves as an education hub for botanists and the general public. “It brings together education, aesthetics, and recreation,” says N Kumar, Vice-Chancellor of TNAU. “The garden is a zero-plastics zone and we ensure that the public strictly adhere to it,” he adds.

The front entrance leads to a renovated play area for children — a cheerful space with multiple swings and colourful slides. An artificial cascade waterfall is being readied. A garden maze with railings is accompanied by rows of clerodendron plants, with tiny white flowers. “These are evergreen plants and can grow up to two metres and in perfect shape. Children can run and hide themselves among the greenery,” says M Ganga, Associate Professor from the Department of Floriculture.

A scented trail

  • I pluck a few leaves from a stevia plant and chew them. They give me an instant sugar rush. “It’s a bio-sweetener, 100 times sweeter than sugar,” says L Nalina, Associate Professor at Department of Floriculture, who specialises in medicinal plants.
  • She adds, as we walk through the herbal and aroma garden that has a valuable collection of over 100 species, “We educate on identification, conservation, and uses of herbal and aromatic plants to the students. The public can also gain knowledge.”
  • Along with plants like nilavembu, brahmi and different varieties of basil, there are species like Thai long pepper ( yaanai thippili), Coleus, aaatukaal kilangu (a tuber shaped like goat’s legs), Malabar spinach and sweet flag (vasambu).
  • The aroma garden has some of the amazing-smelling plants, from the fragrant chamomile and cape jasmine to lavender, thyme, oregano, peppermint, rosemary and cloves.

A little distance away is a five-tiered sunken garden. It has a central pond laid below the ground level, and terraces around it. It also features steps embellished with flowering shrubs like pink euphorbias, and ruellias with pink, white and purple flowers.

“The Department of Floriculture maintains the garden. It’s a tropical botanical garden and serves as an eduction centre for floriculture students to learn about landscaping and concepts of floriculture as it is a part of the syllabus,” explains Kumar.

Along with the existing plants and trees, a number of new species have been added, like the branched palm sourced from the Royal Botanical Garden of Kolkata. A cluster of male and female branched palm trees stands still and picturesque overlooking the four-lawn green turf, developed with Mexican grass.

Beyond flowers and petals

Other attractions include a bambusetum with 15 species of bamboo, a rock garden with cacti species, and a palmatum with diverse palm species.

Plant conservatory with 400 protected species

Plant conservatory with 400 protected species  
| Photo Credit:
Siva Saravanan S

We stop by and glance at a beautiful pink flower, ( It’s the desert rose, a hardy plant, says Ganga) before moving on take a look at the trellis decked up with purple wreath, a lovely small climber with drooping violet-purple star-like flowers, yellow tabebuias and wild alamandas. A mound lawn with undulating elevations comes into the view, a place to sit and watch beautiful views of the garden. We walk past sivakundalam (sausage tree) and 100-year-old gulmohar trees with buttressed roots, to reach the plant conservatory, where plants are nurtured and protected in a green house with shade net.

Play area for children gets a facelift

A sprinkler water system creates a misty environment for the plants. There are anthuriums, birds of paradise, heliconias, rose grape cluster plants, peace lily, and more.

“These species require high humidity. Most of these plant species are rare, endangered or threatened. These species cannot withstand direct sunlight, so we nurture them under diffused light,” explains Ganga.

These efforts are taken for a solid reason, explains Kumar, “Our objective is to reach out to the public. A love for flora should eventually lead to conservation.”

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

National Vaccination Day 2021: History, Theme and Significance

[ad_1]

Read More/Less


Vaccines are essential to help us develop immunity against deadly diseases. With the present Coronavirus pandemic claiming about 2.66 million lives, vaccination has once again acquired paramount importance. On the occasion of the National Vaccination Day 2021, we take a brief look at its history, significance, objectives and this year’s theme.

History March 16 is observed as national Vaccination Day by the Government of India, every year. It was on March 16, 1995, when the day was first celebrated officially after the Pulse Polio Immunisation programme became operational. The first dose of the Oral Polio Vaccine was administered in 1995 on this date, under the World Health Organisation’s (WHO) Global Polio Eradication Initiative which had begun in 1988. Children who were in the age range of 0-5 years were given two drops of the vaccine orally in public health centres. Vaccination against Polio, however, had already started in 1978 and on March 27, 2014, India was declared polio-free, by WHO.

Significance & Objectives On National Vaccination Day, the Government of India seeks to raise awareness about the necessity of immunisation against not just the deadly Poliovirus, but every major viral disease that we do not have natural immunity against. The major vaccines administered in India to children up to 5 years of age are Tetanus, Measles, Rubella, Tuberculosis, Hepatitis-B, Meningitis, Pneumonia, Diptheria, and Pertussis. Covid-19 vaccines for the vulnerable group are the latest addition.

Theme The theme for this year’s National Vaccination Day is both Polio eradication as well as the current COVID-19 threat. Vaccination schedules to eradicate the SARS-CoV-2 virus are being run across the nation.

Covid-19 The virus known as SARS-CoV-2, reportedly began spreading from China and then reached the rest of the world. Clinical trials of a vaccine named ‘Covaxin,’ developed by Bharat Biotech, began in India on July 24, last year. On January 16, this year, the first phase of vaccination for the virus began in the country. By March 15, over 3.15 crore Indians received COVID-19 vaccines.

[ad_2]

READ FULL ARTICLE HERE

Boston Marathon: Boston Marathon to cap entrants at 20,000 amid Covid-19 | More sports News – Times of India

[ad_1]

Read More/Less


This year’s Boston Marathon will be limited to 20,000 entrants in a bid allow greater social distancing throughout the course given the Covid-19 pandemic, race organisers said on Monday.
The number of entrants being allowed for this year’s race, scheduled to be held on October 11, is 33% below the typical number of runners at one of the world’s most prestigious marathons.
The Boston Athletic Association (BAA), which organises the marathon, said it worked closely with local, city, and state partners to establish an appropriate field size for the race that extends from the suburb of Hopkinton to downtown Boston.

“In addition to a smaller field than in previous years, we will have significant additional protocols in place to ensure participant and public health,” BAA. President Tom Grilk said in a news release.
The Boston Marathon, which is typically held in April and generally draws over 30,000 runners from all over the world, had been held annually since 1897 until it was cancelled for the first time in its history last year because of Covid-19.
The global pandemic also forced organisers to push back the date for this year’s race.
As a result, all six marathon majors scheduled this year will now be condensed into a six-week window, starting with the Berlin Marathon on September 26 and ending with the New York City race on November 7.
The 2019 Boston Marathon had 30,234 entrants, according to the BAA website.



[ad_2]

READ FULL ARTICLE HERE

India vs England: Remaining T20Is in Ahmedabad to be played behind closed doors due to COVID-19 | Cricket News – Times of India

[ad_1]

Read More/Less


AHMEDABAD: The remaining three T20 International matches between India and England will be played here without spectators in the wake of rising COVID-19 cases, Gujarat Cricket Association vice-president Dhanraj Nathwani said on Monday.
“T20s on March 16, 18 and 20 will be played without an audience at Narendra Modi Stadium in Ahmedabad. Refunds will be given to the spectators who have purchased tickets,” Nathwani said in a statement.

“Due to the rise in the number of Corona cases, we at GCA have decided in consultation with BCCI, the matches will be played behind closed doors and not allow the spectators in the ground during T20 Internationals to be played between India and England at Ahmedabad.”
He said the GCA will form a policy for refund of money to the spectators who have already purchased tickets for these three T20Is.

“Those who have received complimentary tickets are requested not to visit the stadium,” he added.
The first two games at the world’s largest cricket stadium had attracted more than 60,000 spectators, raising questions over the safety of the fans amid the pandemic.
Crowds had returned for international cricket matches in India during the preceding Test series barring the opening game which was played behind closed doors.
BCCI statement:
The Board of Control for Cricket in India (BCCI) in consultation with the Gujarat Cricket Association (GCA) has decided to conduct the final three T20Is against England at the Narendra Modi Stadium behind closed doors. The decision was arrived at following detailed discussions with the state and local health authorities.
The BCCI will continue to comply with all the regulations put in place to curb the spread of the Covid-19 virus and will always put the health and safety of its fans and stakeholders at the top.
Those who have purchased tickets for any or all three T20Is will be refunded and the process for the same will be announced in due course.



[ad_2]

READ FULL ARTICLE HERE

Germany, France, Italy Suspend Use of AstraZeneca Vaccine Amid Blood Clot Reports

[ad_1]

Read More/Less


Germany, France and Italy on Monday became the latest countries to suspend use of AstraZeneca’s COVID-19 vaccine over reports of dangerous blood clots in some recipients, though the company and European regulators have said there is no evidence the shot is to blame.

ALSO READ: No Evidence Of Increased Blood Clot Risk From Vaccine, Says AstraZeneca

Germany’s health minister said the decision was taken on the advice of the country’s vaccine regulator, the Paul Ehrlich Institute, which called for further investigation into seven reported cases of clots in the brains of people who had been vaccinated.

“Today’s decision is a purely precautionary measure,” Jens Spahn said.

French President Emmanuel Macron said his country would likewise suspend shots at least until Tuesday afternoon, when the European Union’s drug regulatory agency will weigh in on the vaccine. He said France hopes to resume using the formula soon.

Italy’s medicines regulator also announced a precautionary, temporary ban.

AstraZeneca said on its website that there have been 37 reports of blood clots out of more than 17 million people vaccinated in the 27-country European Union and Britain. The drugmaker said there is no evidence the vaccine carries an increased risk of clots.

In fact, it said the incidence of clots is much lower than would be expected to occur naturally in a general population of this size and is similar to that of other licensed COVID-19 vaccines.

The European Medicines Agency and the World Health Organization have also said that the data does not suggest the vaccine caused the clots and that people should continue to be immunized.

The AstraZeneca shot has become a key tool in European countries’ efforts to vaccinate their citizens against COVID-19. But Pfizer’s and Moderna’s vaccines are also used on the continent, and Johnson & Johnson’s one-shot vaccine has been authorized but not yet delivered.

In the US, which relies on the Pfizer and Moderna vaccines, AstraZeneca is expected to apply any day now for authorization.

Blood clots can travel through the body and cause heart attacks, strokes and deadly blockages in the lungs. AstraZeneca reported 15 cases of deep vein thrombosis, or a type of clot that often develops in the legs, and 22 instances of pulmonary embolisms, or clots in the lungs.

Denmark last week became the first country to temporarily halt use of the AstraZeneca vaccine in recent days to investigate. It said one person developed clots and died 10 days after receiving at least one dose. The other countries include Ireland, Thailand, the Netherlands, Norway, Iceland, Congo and Bulgaria.

Last week, Germany and France were among the nations that stuck by the shot, while Italy suspended only a specific batch of the vaccine. Britain is standing by AstraZeneca’s vaccine for now.

Spahn, the German health minister, said of the decision to suspend the AstraZeneca shot: “The most important thing for confidence is transparency.” He said both first and second doses of the vaccine would be affected by the suspension.

German authorities have encouraged anyone who feels increasingly ill more than four days after receiving the shot — for example, with persistent headaches or dot-shaped bruises — to seek medical attention.

Germany has received slightly over 3 million doses of the AstraZeneca vaccine. Spahn said about 1.6 million doses of the shot have so far been administered in the country.



[ad_2]

READ FULL ARTICLE HERE

Antibodies raised by COVID-19 vaccine less effective against some coronavirus variants: Study – Times of India

[ad_1]

Read More/Less


According to a new study, antibodies induced by some COVID-19 vaccines are less effective at neutralising the new circulating variants of the novel coronavirus, such as the ones reported in the UK, Brazil and South Africa.

The study was published in the journal Cell and noted that the neutralising antibodies induced by the Pfizer and Moderna COVID 19 vaccines were less effective against the coronavirus variants first found in South Africa and Brazil.

As per the scientists, neutralising antibodies work by binding tightly to the virus and blocking it from entering the cells and thus preventing infection. That said, this binding only happens when the antibodies and viruses perfectly match, like a key in a lock.

If the shape of the virus changes when the antibody attaches to it, the antibody may no longer be able to recognise and neutralise the virus.

The scientists compared how well the antibodies worked against the original strain versus the new variants.

When the scientists tested the new strains against vaccine-induced neutralising antibodies, they found the three new strains first described in South Africa were 20-40 times more resistant to neutralisation.

The two strains first described in Brazil and japan were five to seven times more resistant as compared to the original SARS-CoV-2 virus lineage from Wuhan, China.

“In particular we found that mutations in a specific part of the spike protein called the receptor-binding domain were more likely to help the virus resist the neutralizing antibodies,” said one author of the study.

However, the ability of these variants to resist neutralising antibodies doesn’t mean the vaccines won’t be effective.

“The body has other methods of immune protection besides antibodies. Our findings don’t necessarily mean that vaccines won’t prevent COVID, only that the antibody portion of the immune response may have trouble recognizing some of these new variants,” said the scientists.

To develop the next generation it’s important to understand which mutations are more likely to allow the virus to evade vaccine-derived immunity.

The study can also help researchers develop more effective preventative methods, such as a broadly protective vaccine that works against a wide variety of variants, regardless of the number of mutations that develop.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus | COVID-19 vaccine rollout needs course correction in the face of resurgence

[ad_1]

Read More/Less


The recent rise in COVID 19 cases in six states, accounting for 85% of reported new cases, is disturbing. The concerned State Governments and the Union Ministry of Health need to seriously soul search and quickly arrive at a plan of action to quell the resurgence by vaccination. The resurgence is most likely due to: the general public throwing caution to the wind – discarding the disciplined use of masks, hand hygiene and physical distancing; and engaging in activities leading to mass gatherings – including weddings and funerals – that are conducive to spreading the virus. Opening up of transport services in general and suburban train services in Mumbai in particular, would have contributed to the resurgence.

Regulatory agency authorised emergency use of two COVID-19 vaccines on January 3. On January 16, both were made available to healthcare professionals, the first priority, followed by those in essential services. From March 1, the second phase has begun when senior citizens and those above 45 with co-morbidities are the next priority for vaccination; the Government is expanding the coverage in a phased manner, starting with selected segments of society and expanding to cover more. India’s COVID vaccination programme will be world’s second largest because we have the second largest population in the world. However in the face of the resurgence of cases in six states, should there not be a change in strategy?

The right goals

Setting goals for wide vaccination coverage systematically is an administrative activity. Health management approach would have a different goal. Since health management has two arms, public health and healthcare, each would have its own goal – a healthcare goal and a public health goal.

The healthcare goal is to mitigate adverse disease outcomes, the hierarchy is, for preventing: death; disease becoming severe to require intensive care; hospitalisation per se and finally, symptomatic disease. Here, need-based vaccine coverage has to begin on the basis of vulnerability to these outcomes – hence vaccination should be prioritised for oldest down to 65 years; all below 65 with co-morbidity – obesity, hypertension, chronic heart, lung, kidney or liver disease, people with malignancies whether or not on treatment, etc.

The public health goal is to reduce the speed of coronavirus transmission, thereby reducing the community burden of COVID-19. For this vaccination drive should be targeted to the six states in which the speed of transmission is highest – Maharashtra, Punjab, Haryana, Gujarat, Madhya Pradesh and Delhi. In these States, vaccination ought to be undertaken on war footing, even taking the help of the army, for implementation. While vaccine-war progresses in these six States, other States should continue targeted healthcare vaccination of the elderly and the vulnerable.

Economic impact

To overcome the economic impact of the pandemic, civil administration should set up its own independent goals. Priority ought to be for step-wise and safe revival of all stalled activities in various systems – education, law and order, transport, sanitation and general administration. A systematic targeted vaccination plan and platform should be designed for this purpose in relevant locations. Economic revival demands the opening up of all industrial and agricultural activities, and India’s human personnel in these areas ought to be vaccinated systematically.

The attempt to meet this demand by having vaccination centres working 24/7 is a step in the right direction, but more innovative steps need to be taken in order to reach vaccination to the people in rural India. Countries like the U.S. have started using mobile vaccination centres and have established vaccination centres in supermarkets to rapidly cover the entire population. In India a similar approach, especially mobile vaccination units, can rapidly cover many villages.

Even now it is not too late to define goals for public health, healthcare and the administrative segment and plan appropriate strategy and tactics to achieve their respective goals. The three should function in a well-oiled, co-ordinated and seamless manner to achieve their targets.

The public, including healthcare professionals, apparently misunderstood that the vaccine roll-out was premature without stating its purpose or it was for political reasons – to showcase one of the world’s largest vaccination programmes by making it a well-orchestrated drill. But when unaccompanied by sharing of authentic and authoritative information, it led to wide-spread vaccine hesitancy. Public health programmes rely heavily on information-education-communication – after all if people understand that vaccination is for their own good and for the benefit of the entire nation, they will willingly cooperate.

Education

So, concurrently with planning the revised strategy, there should be a health education blitzkrieg about the benefits of the vaccination for the individual and for the community – so that people may knowingly and willingly participate in it. It can easily be accomplished since we are well-versed in vigorous campaigns for various purposes.

If India demonstrates its ability to set-up this model, and execute the world’s second largest vaccination programme to perfection, it will be worthy of emulation in all countries of the world.

(T. Jacob John is retired professor of clinical virology, Christian Medical College, Vellore. M.S. Seshadri is retired professor of medicine (endocrinology), CMC and medical director of Thirumalai Medical Mission Hospital, Ranipet. )

This story is available exclusively to The Hindu subscribers only.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

1 4 5 6 7 8 13